Sign Out
Active immunisation against encephalitis due to Japanese encephalitis virus
Adult: As inactivated, adsorbed vaccine: Primary immunisation: 0.5 mL for 2 doses given 28 days apart. Alternatively, doses may be given 7 days apart as a rapid administration schedule. Booster dose: 0.5 mL as a single dose given between 12-24 months after the primary immunisation, before potential re-exposure to Japanese encephalitis virus. Doses are given via IM inj into the deltoid muscle. Recommendations may vary between individual products or local immunisation guidelines (refer to latest product or country guidelines).
Child: As inactivated, adsorbed vaccine: Primary immunisation: 2 months to <3 years 0.25 mL for 2 doses given 28 days apart; 3-17 years Same as adult dose. Booster dose: 14 months to <3 years 0.25 mL as a single dose given between 12-24 months after the primary immunisation, before potential re-exposure to Japanese encephalitis virus; 3-17 years Same as adult dose. Doses are given via IM inj into the anterolateral aspect of the thigh (2 months to <3 years) or deltoid muscle (3-17 years). Recommendations may vary between individual products or local immunisation guidelines (refer to latest product or country guidelines).
Child: As inactivated, adsorbed vaccine: Primary immunisation: 2 months to <3 years 0.25 mL for 2 doses given 28 days apart; 3-17 years Same as adult dose. Booster dose: 14 months to <3 years 0.25 mL as a single dose given between 12-24 months after the primary immunisation, before potential re-exposure to Japanese encephalitis virus; 3-17 years Same as adult dose. Doses are given via IM inj into the anterolateral aspect of the thigh (2 months to <3 years) or deltoid muscle (3-17 years). Recommendations may vary between individual products or local immunisation guidelines (refer to latest product or country guidelines).
Subcutaneous
Active immunisation against encephalitis due to Japanese encephalitis virus
Adult: Primary immunisation: As live-attenuated vaccine or live-attenuated, recombinant vaccine: 0.5 mL as a single dose. Booster dose: As live-attenuated vaccine: 0.5 mL as a single dose given 3 months to 1 year after the primary immunisation. As live-attenuated, recombinant vaccine: 0.5 mL as a single dose given up to 5 years after the primary immunisation. Doses are given via SC inj into the deltoid region of the upper arm. Recommendations may vary between individual products or local immunisation guidelines (refer to latest product or country guidelines).
Child: >9 months Primary immunisation: As live-attenuated vaccine or live-attenuated, recombinant vaccine: Same as adult dose. Booster dose: As live-attenuated vaccine: Same as adult dose. As live-attenuated, recombinant vaccine: 0.5 mL as a single dose given 12-24 months after the primary immunisation with a live-attenuated vaccine; a single 0.5 mL dose may also be given in children who have previously received an inactivated vaccine, in accordance with the recommendations on the timing for booster doses of inactivated Japanese encephalitis vaccines. Doses are given via SC inj into the anterolateral aspect of the thigh or the deltoid region (9 months to 2 years) or the deltoid region of the upper arm (>2 years). Recommendations may vary between individual products or local immunisation guidelines (refer to specific product or country guidelines).
Child: >9 months Primary immunisation: As live-attenuated vaccine or live-attenuated, recombinant vaccine: Same as adult dose. Booster dose: As live-attenuated vaccine: Same as adult dose. As live-attenuated, recombinant vaccine: 0.5 mL as a single dose given 12-24 months after the primary immunisation with a live-attenuated vaccine; a single 0.5 mL dose may also be given in children who have previously received an inactivated vaccine, in accordance with the recommendations on the timing for booster doses of inactivated Japanese encephalitis vaccines. Doses are given via SC inj into the anterolateral aspect of the thigh or the deltoid region (9 months to 2 years) or the deltoid region of the upper arm (>2 years). Recommendations may vary between individual products or local immunisation guidelines (refer to specific product or country guidelines).
Lanjutkan dengan Google